• Vt. to get $1.1 million drug settlement
    November 17,2012
    • Email Article
    •  
    •  Print Article
     
    MONTPELIER — Vermont’s attorney general says the state will receive $1.1 million as part of a national settlement with pharmaceutical manufacturer GlaxoSmithKline over allegations that the company deceptively marketed a diabetes drug.

    The complaint accuses GlaxoSmithKline LLC of engaging in unfair and deceptive practices by misrepresenting Avandia’s cardiovascular risks and safety profile.

    Vermont Attorney General William Sorrell said Thursday that GlaxoSmithKline has reached a $90 million settlement with 37 other attorneys general and has agreed to change how it markets and promotes diabetes drugs.
    • Email Article
    •  
    •  Print Article
    2 Comments
    MORE IN Vermont News
    BERLIN — A hypodermic needle was found in a baby changing table of the Berlin Mall on Friday,... Full Story
    WATERBURY CENTER — Vermont State Police say a toddler is in critical condition after being found ... Full Story
    LYNDONVILLE — Police say they’ve arrested a third person involved in a string of armed robberies ... Full Story
    More Articles